NM_004792.3:c.122G>A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_004792.3(PPIG):c.122G>A(p.Arg41His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000686 in 1,456,848 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004792.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPIG | NM_004792.3 | c.122G>A | p.Arg41His | missense_variant | Exon 4 of 14 | ENST00000260970.8 | NP_004783.2 | |
PPIG | XM_005246966.3 | c.122G>A | p.Arg41His | missense_variant | Exon 4 of 14 | XP_005247023.1 | ||
PPIG | XM_005246967.2 | c.122G>A | p.Arg41His | missense_variant | Exon 4 of 14 | XP_005247024.1 | ||
PPIG | XM_017005302.3 | c.122G>A | p.Arg41His | missense_variant | Exon 4 of 12 | XP_016860791.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1456848Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 724778
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.122G>A (p.R41H) alteration is located in exon 4 (coding exon 2) of the PPIG gene. This alteration results from a G to A substitution at nucleotide position 122, causing the arginine (R) at amino acid position 41 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.